Skip to content
  • Home
  • About Us
  • Main Business Clinical
    • Main Business Clinical
    • Clinical process
  • Information
    • Newsletter
    • Clinical Trial Information
  • Korea Clinical Trial Status
    • Pharmaceutical Approval Status in Korea
    • Medical Device Approval Status in Korea
  • English
    • English
    • 한국어
Quotation Request
(주)인투인월드 Intoinworld

Connecting people, advancing clinical value

  • Home
  • About Us
  • Main Business
    • Main Business
    • Clinical Trial Process
  • Information
    • Notice
    • Newsletter
    • Clinical Trial Information
      • FDA/EMA Global Submission Strategies
      • Regulatory & Guideline Updates
      • Clinical Trend Insights
      • CRO Knowledge
  • Korea Clinical Trial Status
    • Pharmaceutical Approval Status in Korea
    • Medical Device Approval Status in Korea
  • English
    • English
    • 한국어
Quotation Request
(주)인투인월드 Intoinworld

Connecting people, advancing clinical value

Clinical Trend Insights

Connecting people, advancing clinical value

AI is Transforming Non Clinical Trials through Innovation

AI is Transforming Non Clinical Trials through Innovation

2026/02/04
Read more
AI-Enabled Biopharma in 2026: Sponsor & CRO Playbook for Discovery, Evidence Generation, and Responsible AI

AI-Enabled Biopharma in 2026: Sponsor & CRO Playbook for Discovery, Evidence Generation, and Responsible AI

2026/01/28
Read more
Molecular Glue Degraders in 2026: Clinical Trials Surge, China-Korea Strategy & Korea’s Precision Oncology Edge

Molecular Glue Degraders in 2026: Clinical Trials Surge, China-Korea Strategy & Korea’s Precision Oncology Edge

2026/01/21
Read more
Designing Radiopharmaceutical Theranostic Clinical Trials in South Korea

Designing Radiopharmaceutical Theranostic Clinical Trials in South Korea

2026/01/14
Read more
Korea’s 2026 Cancer Clinical Trials Outlook: Data Trends and Planning Insights

Korea’s 2026 Cancer Clinical Trials Outlook: Data Trends and Planning Insights

2025/12/31
Read more
Top 5 Best‑Selling Drugs in 2025 and Why Korea Is a Strategic Clinical Trial Hub

Top 5 Best‑Selling Drugs in 2025 and Why Korea Is a Strategic Clinical Trial Hub

2025/12/03
Read more
Five Pillars for Global Submission Readiness

Clinical Research Management in the WLA Era: Five Pillars for Global Submission Readiness

2025/11/12
Read more
2025 Korea CDx Co‑Development Guide- Latest Regulations and Submission Strategies

2025 Korea CDx Co‑Development Guide: Latest Regulations and Submission Strategies

2025/11/05
Read more
ADC Clinical Trials in Korea- Drug Conjugates and Value of Domestic CROs_

ADC Clinical Trials in Korea:Drug Conjugates and Value of Domestic CROs

2025/10/29
Read more
  • 1
  • 2

Business registration number

425-87-00267

Tel

+82-2-2038-8082

E-mail

intoin@intoinworld.com

CEO

John Choi

Address

10F, 21, Gukhoe-daero 62-gil, Yeongdeungpo-gu, Seoul, 07236, Korea

  • Privacy Policy
  • Terms of Service
  • Email Collection Prohibited

COPYRIGHT © INTOINWORLD, ALL RIGHT RESERVED